1. Home
  2. SNY vs CAT Comparison

SNY vs CAT Comparison

Compare SNY & CAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
    SELLHOLDBUYas of 2 days ago
  • CAT
    SELLHOLDBUYas of 3 days ago
  • Stock Information
  • Founded
  • SNY 1994
  • CAT 1925
  • Country
  • SNY France
  • CAT United States
  • Employees
  • SNY N/A
  • CAT N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • CAT Construction/Ag Equipment/Trucks
  • Sector
  • SNY Health Care
  • CAT Industrials
  • Exchange
  • SNY Nasdaq
  • CAT Nasdaq
  • Market Cap
  • SNY 144.8B
  • CAT 159.3B
  • IPO Year
  • SNY N/A
  • CAT N/A
  • Fundamental
  • Price
  • SNY $55.82
  • CAT $328.55
  • Analyst Decision
  • SNY Buy
  • CAT Buy
  • Analyst Count
  • SNY 2
  • CAT 16
  • Target Price
  • SNY $62.50
  • CAT $383.80
  • AVG Volume (30 Days)
  • SNY 3.0M
  • CAT 2.6M
  • Earning Date
  • SNY 04-24-2025
  • CAT 04-24-2025
  • Dividend Yield
  • SNY 3.94%
  • CAT 1.71%
  • EPS Growth
  • SNY 2.94
  • CAT 9.59
  • EPS
  • SNY 4.60
  • CAT 22.05
  • Revenue
  • SNY $45,849,466,833.00
  • CAT $64,809,000,000.00
  • Revenue This Year
  • SNY $6.91
  • CAT N/A
  • Revenue Next Year
  • SNY $6.60
  • CAT $5.01
  • P/E Ratio
  • SNY $23.82
  • CAT $14.95
  • Revenue Growth
  • SNY 7.73
  • CAT N/A
  • 52 Week Low
  • SNY $45.22
  • CAT $307.05
  • 52 Week High
  • SNY $60.12
  • CAT $418.50
  • Technical
  • Relative Strength Index (RSI)
  • SNY 47.61
  • CAT 45.52
  • Support Level
  • SNY $53.98
  • CAT $329.21
  • Resistance Level
  • SNY $56.93
  • CAT $347.27
  • Average True Range (ATR)
  • SNY 0.78
  • CAT 6.75
  • MACD
  • SNY -0.56
  • CAT 1.35
  • Stochastic Oscillator
  • SNY 31.19
  • CAT 43.41

Stock Price Comparison Chart: SNY vs CAT

SNY
CAT
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025050100150200250300350400450SNY VS CAT

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About CAT Caterpillar Inc.

Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. Its reporting segments are: construction industries (40% sales/47% operating profit, or OP), resource industries (20% sales/19% OP), and energy & transportation (40% sales/34% OP). Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has global reach (46% US sales/54% ex-US). Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of 156 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use